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Abstract:  ONSET AND EXACERBATION OF OBSESSIVE-COMPULSIVE 
DISORDER IN PREGNANCY AND THE POSTPARTUM PERIOD.  
Mariel A. Focseneanu, C. Neill Epperson.  Department of Psychiatry, Yale University, 
School of Medicine, New Haven, CT. 
 
The overarching goal of this study was two-fold; to determine the prevalence of 
perinatal onset or worsening of OCD symptoms in women attending a university-based 
research program, and to determine whether there is a continuity between perinatal onset 
or worsening of OCD and premenstrual exacerbation of such symptoms.  
Women ages 18 to 69 years old that were enrolled in the Yale OCD Research 
Program between 1990 and 1995 were interviewed by phone or in person regarding 
demographics, onset and course of OCD, types of primary OCD symptoms, treatment 
history, comorbid diagnoses including substance use/abuse, and the impact of pregnancy 
and menstruation on OCD onset and symptoms.  Those who had at least one pregnancy 
were placed into the Preg group and those who had never been pregnant into the NPreg 
group.  The Preg group was further subdivided; those who reported onset of OCD during 
pregnancy or the puerperium were assigned to the Puerperal Related (PR) group while 
those that denied onset of OCD related to pregnancy were assigned to the Non-Puerperal 
(NP) group.  For our secondary aim addressing premenstrual worsening, those women 
who were in the PR group were combined with women with pre-existing OCD that 
worsened during pregnancy or the postnatal period. 
 All data were summarized using descriptive statistics (means, SDs, 
frequencies).  Continuous measures were compared between groups using a Student's t-
test and categorical variables were assessed using the chi-square test.  All analyses were 
considered statistically significant at P <0 .05 and performed using SAS, version 9.1. 
Of the Preg group, 24 (30.8%) fell into the PR subgroup; 11 (14.1%) reported 
onset during pregnancy, 1 (1.3%) had onset after a miscarriage, and 12 (15.4%) had onset 
during the postpartum period.  Out of 132 total pregnancies, 29 (22.0%) involved an 
improvement in OCD symptoms, 45 (34.1%) involved an exacerbation of symptoms, and 
58 (43.9%) did not change symptom severity in women with pre-existing illness.  
Although worsening of symptoms prior to menses was reported by the same proportion 
of women in the Preg group as in the NPreg group, women in the PR group and those 
with perinatal exacerbation were more likely to report premenstrual worsening of OCD 
symptoms compared to all others. 
Findings from this study provide additional evidence that pregnancy and 
childbirth are frequently associated with the onset of OCD or worsening of symptoms in 
those with pre-existing disorder.  In addition, there appears to be continuity between 
OCD onset and/or exacerbation across the reproductive life cycle, at least with 
menstruation and pregnancy.  These data can not address the impact of menopause on 
OCD symptoms.  Our findings are consistent with those from other groups, but all need 
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I. Background and Rationale 
 
Pregnancy and the puerperium (postpartum) are stages of life traditionally 
associated with emotions such as happiness, joy, and excitement for a new mother and 
her family.  However, there are accounts of puerperal mental illness since the time of 
Hippocrates.  Primitive theories of the etiology of these childbirth-related disturbances 
involved uterine vapors, toxins, and deposits of milk in the brain.  Recent speculations 
about the causes of puerperal mental illness highlight the importance of psychodynamic 
issues, alterations in the neuroendocrine milieu and psychosocial/interpersonal stressors 
both specific and nonspecific to childbearing (1).  It is now well known that the 
puerperium represents a time of increased vulnerability to psychiatric disorders, 
particularly depression, psychosis, and the largely understudied obsessive-compulsive 
disorder.  OCD in the postpartum period often goes undiagnosed and thus untreated, 
resulting in devastating consequences for the patient, her family, and the newborn. 
   
1.a. Phenomenology and Natural History of OCD 
    
       Obsessive-compulsive disorder is an anxiety disorder characterized by recurrent, 
intrusive thoughts or ideas that are recognized as being senseless, yet give rise to anxiety 
and distress.  In addition, the individual feels urges to perform excessive rituals to 
neutralize or suppress these disturbing feelings.  Avoidance of situations related to 




function at home, work and/or in the social/familial realm.  The specific content of 
obsessions and compulsions is highly variable and patient-dependent, but a common 
theme concerns uncertainty over responsibility for harm or mistakes.  Common themes 
for obsessional thoughts include:  fears of contamination, aggression or violence, 
inappropriate sexual activity, need for symmetry, and concerns about making mistakes.  
Compulsive behaviors may involve ritualistic checking, washing, counting, or repeating 
routine activities.  The onset of OCD is typically gradual, occurring over months to years 
(2). 
OCD is one of the most common psychiatric disorders in the world, with an 
estimated lifetime prevalence rate of 2-3% in the general adult population (3).  Unlike 
depression, which has a female predominance, OCD affects male and female adults 
roughly equally (4, 5).  Without effective treatment, the course of the illness is usually 
chronic and deteriorating, with symptoms interfering significantly with daily functioning 
in multiple aspects of life.         
   
1.b. Phenomenology and Prevalence of OCD During Pregnancy 
 
Many studies in recent years have focused on postpartum depression or 
psychoses, but little effort has been devoted to studying OCD in the perinatal context. 
Interpretation of findings from early studies is complicated by antiquated diagnostic 
methods and/or relatively small sample sizes, in addition to being primarily case series 
and retrospective reports.  To date, no studies have confirmed subject reports of perinatal 




prevalence rates of pregnancy or postpartum onset OCD or exacerbation of OCD are 
unknown (6).  The wide range of percentages reported in the following studies may be a 
result of the differing methods of data collection, lack of uniform diagnostic criteria, and 
the innate differences in patient populations. 
In 1957, Pollitt found that pregnancy and childbirth were associated with the 
onset of obsessive symptoms in 11% of 93 patients with OCD (7).  Ingram (1961) noted 
in his retrospective review of 89 inpatients with “obsessional states” that for 16.9% of the 
group, the onset had occurred in association with pregnancy, making it the most common 
precipitating event (8).  However, Lo (1967) reported such an association in only 5% of 
56 OCD patients (9).   
More recently, Buttolph and Holland (1990), using a questionnaire limited by a 
33% response rate, reported that OCD began during pregnancy in 15% of 39 women and 
during the postpartum period in 21% (10).  Neziroglu and colleagues found that 
approximately 40% of the 64 women with OCD (professionally diagnosed according to 
DSM-IIIR criteria) in their study who had been pregnant experienced initial symptom 
onset during one of their pregnancies (11).  In a related case series, Sichel et al. (1993) 
reported on fifteen non-depressed patients with new-onset OCD beginning early in the 
postpartum period.  Eight women had no previous psychiatric history, and all the patients 
responded well to treatment with a serotonergic reuptake blocker (12).  On the other 
hand, Williams and Koran (1997) reported that only 13% of women in their series who 
had been pregnant associated the onset of their OCD (according to DSM-IV criteria) with 
pregnancy (13).  Maina et al. (1999) reported the onset of OCD at postpartum in 50% of 




Labad (2005) and colleagues of 46 female OCD patients found that OCD onset occurred 
at pregnancy in 2% and at postpartum in 7% of the subjects (15). 
In addition to these examples of initial symptom onset occurring during the 
perinatal period, available research also yields some evidence of exacerbation of pre-
existing OCD during this time.  In 1987, the first report of a case of OCD exacerbation 
during pregnancy was published, describing a 26-year-old woman with a fluctuating 
course of the illness who experienced a severe and prolonged decompensation during her 
second pregnancy (16).  Buttolph and Holland (1990) reported that 69% of the 39 female 
OCD patients in their study described a relationship between the onset or an exacerbation 
of OCD and some aspect of pregnancy, birth, or care of their children.  OCD worsened 
during pregnancy in 8% of the women, and during the postpartum period in 15%. 
Triggering events included infertility, miscarriage, pregnancy, birth and care of the first 
child, and birth and care of subsequent children (10).   
In another study, miscarriage was a significant risk factor for the recurrence of 
OCD in women with pre-existing illness (17).   In Labad’s study, worsening of pre-
existing OCD was reported by 8% of patients at pregnancy and 50% at postpartum (15).  
Overall, however, the data on OCD exacerbation during pregnancy is limited and 
somewhat equivocal.  For example, in the study described above by Williams and Koran, 
69% of the 29 women with pre-existing OCD described no change in symptoms during 
pregnancy.  17% described worsening, and 14% described improvement.  However, 
postpartum exacerbation of OCD symptoms was noted by 29% of the patients (13).  
Altshuler et al. noted that exacerbation of pre-existing OCD is common in women after 




OCD is a heterogeneous disorder in that it can present with a wide variety of 
obsessions and compulsions.  Despite this diversity of symptoms, previous studies appear 
to show a consistent pattern during the puerperium with regard to content of the 
obsessions and compulsions.  For example, it appears that contamination obsessions and 
washing or cleaning rituals are prevalent during pregnancy, while postpartum OCD tends 
to be manifested as ego-dystonic intrusive obsessional thoughts of harming the infant, 
accompanied by avoidance behaviors or checking rituals (11, 13, 14, 19, 20).  In contrast 
to the gradual onset of typical OCD, postpartum OCD appears to be characterized by the 
rapid onset of obsessional symptoms after the birth.  As an example, in the case series 
mentioned above by Sichel’s group, the mean time to onset of OCD symptoms was 2.2 
weeks after delivery.  These symptoms presented primarily as intrusive obsessional 
thoughts of harming their babies.  Although no associated compulsive rituals developed, 
as would be expected in the course of classical OCD, all the women exhibited some 
degree of avoidance behavior toward their infants as a response to these obsessions which 
they found to be extremely frightening and disturbing (19).  In another case series, the 
mean time of onset of OCD symptoms was 3.7 weeks following delivery, with onset as 
early as the second postpartum day reported (21).     
  
1.c. Neurobiology - Evidence Linking Serotonin, Gonadal Hormones, and OCD  
 
In the past, research on neuropsychiatric disorders has often attempted to 
associate each disorder with either a deficiency or an excess within a single 




developed as a result of the finding that serotonin reuptake inhibitors (SRIs) are the most 
effective treatment for OCD.  However, further studies gave no definitive evidence that a 
dysregulation of serotonin function was the primary or only neurochemical disturbance in 
OCD.  Moreover, only 40-60% of OCD patients respond to SRI monotherapy, and even 
these patients may only have a partial response.  Thus it must be acknowledged that SRIs 
also act via other neurotransmitter systems, and it is likely that OCD is a result of a 
disturbance in several of these neurochemical pathways (22).  In a comparison of four 
studies of various SRIs in OCD patients via meta-analysis, it appeared that greater 
improvement in OCD symptoms was actually associated with less selectivity for 
serotonin (23).  Both serotonergic and dopaminergic systems appear to have a modulating 
effect on elements of the basal ganglia circuit that are implicated in OCD, suggesting that 
certain cases of OCD (for example, with tics) may respond best to an SRI-neuroleptic 
combination (24, 25).  Reviewers have also hypothesized that a relative excess of basal 
ganglia dopaminergic activity underlies compulsive behaviors (26).     
A limited number of imaging studies investigating anatomic brain regions 
involved in OCD have been published to date.  Although the studies are small and have  
varied results, there is some convergence of the data indicating involvement of the 
orbitofrontal cortex, the caudate, and the anterior cingulate cortex (27, 28).  As further 
evidence of involvement of the caudate nucleus, a number of disorders associated with 
abnormalities in the caudate including Tourette’s syndrome, Sydenham’s chorea, 
Parkinson’s disease, and Huntington’s disease, are frequently accompanied by obsessive 




Since pregnancy and/or childbirth appear to exacerbate or contribute to the onset 
of OCD in a sizable portion of women, investigators have theorized that pregnancy-
specific psychosocial stresses, parenting responsibilities, and/or changes in the 
neuroendocrine milieu are the most likely contributors to this phenomenon.  During 
pregnancy, there is a profound increase in gonadal steroid (estrogen and progesterone) 
levels over 9 months of gestation, only to be followed by a precipitous drop in both 
estradiol and progesterone to hypogonadal levels within 48 hours (29).  It has been 
hypothesized that the extreme fluctuations in these hormones may have an adverse 
impact on serotonergic function, producing the notably acute onset of symptoms early in 
the postpartum period (12).  Few studies have actually tested this hypothesis, but results 
from studies in postpartum rats indicate that serotonin receptor changes in the limbic area 
are negatively correlated with progesterone levels (30).  While between estradiol, 
progesterone, and its neurosteroid derivative allopregnanolone (ALLO), multiple 
neurotransmitter systems are modulated, the relationship between these steroids and 
serotonin have seemed most relevant in the context of OCD in the perinatal period.   
The effects of gonadal steroids on serotonin are complex and region specific, but 
it is clear that serotonergic neurotransmission (i.e., synthesis, metabolism, uptake, and 
receptor sites) is at least partially modulated by changes in estrogen and progesterone 
(31-33).  Estrogens were found to exert a biphasic effect on the density of serotonin 
receptors in the female rat brain: an acute reduction in serotonin receptor density 
throughout the brain is followed 48 to 72 hours later by a selective increase in those brain 
regions known to contain estrogen receptors--hypothalamus, preoptic area, and amygdala 




and recovered completely after giving birth, suggesting a strong biological influence on 
the development of the illness; after the hormonal changes abated, the symptoms 
disappeared as well (20).  It should be noted, however, that this case differs from most 
reports of OCD onset during pregnancy, in which the symptoms continued or recurred 
after birth.   
As further evidence for a temporal relationship between manipulation of gonadal 
hormones and a change in OCD symptoms, there have been several case reports 
documenting the onset or exacerbation of OCD associated with administration of oral 
contraceptives, which alter the individual’s neuroendocrine milieu.  In two of these cases, 
discontinuation of the exogenous hormones led to clinical improvement (35, 36).   
Although all studies have been based on retrospective reports, it appears that a 
sizable proportion of women with OCD experience an exacerbation of their primary 
symptoms during the premenstruum, thus lending further evidence that ovarian hormones 
may contribute to the pathogenesis of OCD in such cases, if not in general (4, 37).  In the 
Williams and Koran study previously discussed, 42% of the women surveyed reported 
regular premenstrual worsening of their OCD (13).  Similarly, the Labad study found that 
OCD onset occurred in the same year as menarche in 22% of their subjects, and 
worsening of preexisting OCD during the premenstruum was reported by 20%.  In 
addition, the number of premenstrual mood symptoms (including anxiety, irritability, 
mood lability, and depressed mood) was associated with both premenstrual worsening of 
primary OCD symptoms, and onset or worsening of OCD during the puerperium.  
Patients with an onset or exacerbation of OCD during the puerperium also more 




depressive disorder, including postpartum depression (15).  Premenstrual dysphoria and 
high rates of postpartum depression have also been described in female OCD patients in 
general (12, 13).  Likewise, women with a history of premenstrual syndrome are at higher 
risk for postpartum depression and psychosis (38).  To link all of these observations, it 
has been proposed that a common dysregulation of serotonergic neurotransmission, 
which can be accentuated by ovarian steroid fluctuations, may be involved in the 
pathophysiology of OCD, postpartum depression, and premenstrual syndrome (24, 39).      
 
1.d. Evidence For Oxytocin Involvement in the Pathogenesis of OCD 
 
While serotonin was the initial and has been the primary neurotransmitter 
investigated in the pathophysiology of OCD, poor treatment response to SRIs in up to 
40% of OCD patients has made it critical to shift focus to other possible contributors.  
Most recently, the hormone oxytocin (40) and neurotransmitters dopamine (41) and 
glutamate (42) have been of considerable interest.   Given the role of oxytocin in 
parturition and lactation, this overview will be limited to discussion of studies examining 
oxytocin’s role in OCD.  Oxytocin is a nonapeptide synthesized primarily in the 
paraventricular and supraoptic nuclei of the hypothalamus, which project to the posterior 
pituitary gland (43).  Pituitary release of oxytocin into the bloodstream increases in late 
pregnancy and the postpartum period, where it stimulates uterine contractions and milk 
ejection.  Notably, oxytocin has also been implicated as a centrally active neuropeptide 
responsible for stimulating sexual, maternal, grooming, and affiliative behaviors in 




that oxytocin has been purported to play a role in the pathogenesis of OCD.  It has been 
suggested that the increase in autogrooming observed with oxytocin administration in 
rodents (47), for example, may be similar to the repetitive hand washing and cleaning 
present in many patients with OCD (40).  It is equally conceivable that obsessions 
regarding the infant’s safety and compulsions such as checking are pathological 
correlates of normal maternal behavior; most new mothers are understandably vigilant 
about their baby’s health and welfare.  
These central effects may be mediated by projections of oxytocinergic neurons to 
extrahypothalamic brain areas, including regions of the brainstem and forebrain (48).  For 
example, it has been shown that oxytocin fibers from the paraventricular nucleus project 
to structures of the limbic system (49), one of the prime candidates for a possible 
anatomic site of dysfunction in OCD (22).  To further support the association between 
oxytocin and OCD, in a 1994 study, Leckman et al. found correlations between 
cerebrospinal fluid oxytocin levels and OCD severity among untreated patients (50).   
 Interestingly, ovarian steroids (namely estrogen) influence both neurosecretory 
and intracerebrally projecting oxytocinergic neurons.  The concentration of oxytocin and 
its receptor in the CNS are responsive to circulating steroid levels (51).  For example, 
estrogen treatment stimulates the release of oxytocin into the peripheral circulation (52) 
and induces oxytocin binding sites in the brain (53).  It is unknown how estrogen 
mediates these changes, although apparently a subpopulation of oxytocinergic neurons 
have binding sites for estradiol (54).  In addition, in examination of female rats 




neuronal oxytocin mRNA; they observed a significant increase in oxytocin mRNA 
concomitant with puberty and reversible with ovariectomy (48). 
Thus the brain, in addition to mammary and uterine tissue, appears to be a target 
organ for oxytocin in the postpartum period.  As further support of this hypothesis, Insel 
demonstrated an increase in oxytocin binding in the bed nucleus of stria terminalis 
(BNST) of rats during the postpartum period (55).  Oxytocin is elevated in the third 
trimester of pregnancy and early postpartum period, which coincides with the time that 
many women report onset of obsessive-compulsive symptoms.  Vaginocervical 
stimulation, which occurs with a miscarriage or abortion, has also been shown to increase 
oxytocin levels (56), which gives a plausible explanation for the occurrence of these 
symptoms after a fetal loss.   
However, in contrast to Leckman’s finding of increased CSF oxytocin levels in 
patients with OCD, two other studies reported no correlation between OCD symptoms 
and CSF oxytocin levels (57, 58).  In addition, several investigators attempting to treat 
OCD with intranasal oxytocin have reported inconsistent results (59, 60).  Most recently, 
Epperson et al. found that intranasal oxytocin, even at 3 and 6 times the dosages 
previously tested, had no effect on obsessive-compulsive symptoms (61).  Given the 
difficulty in getting peripherally administered oxytocin across the blood-brain barrier and 
into the CNS, it is difficult to conclude that a negative finding indicates no association 
between oxytocin and OCD; thus methods must be developed to investigate central 
oxytocin function in this disorder.   
Still, there are problems with assuming a purely biological (neurohormonal) 




hormonal “imbalances” play a causal role.  Gonadal hormone influences on CNS 
serotonin function vary with length of exposure, dose, and species.  In general, the 
precise neurobiological mechanisms of OCD remain unclear, and research in this area is 
still preliminary.  Moreover, biological theories alone do not account for the evident 
specificity in symptom presentation among women with puerperial onset OCD.  
Abramowitz et al. (2001) also reported an interesting finding of an onset or exacerbation 
in OCD symptoms among new fathers, which is inconsistent with a purely biological 
model and suggests that the transition to parenthood may entail other factors which 
unmask the vulnerability to OCD in these individuals (62). 
              
1.e. Genetic Predisposition to Illness 
 
Although many women with postpartum psychiatric illness have no prior 
psychiatric history, there is often a strong family history of affective disorders, 
particularly depression and postpartum depression (38).  Since the dramatic hormonal 
changes described above occur as part of the reproductive cycle in all women, it seems 
that the development and exacerbation of mood disorders and OCD at these vulnerable 
periods requires more than just fluctuating hormone levels, but also a genetic 
predisposition.  These currently unidentified genetic “defects” probably relate to subtle 
alterations in the number and function of certain receptors and enzymes, as well as minor 
structural and anatomical differences in the CNS (39).  
There appears to be a definite familial concentration of OCD (63-65).  




population of subjects revealed that a sexually dimorphic pattern of genetic susceptibility 
to OCD may be present (37).  These findings were consistent with several earlier studies 
of genetics in OCD (63, 66, 67).     
Comorbidity data and family genetic studies indicate that 10-20% of OCD cases 
probably have a biological relationship to Tourette’s syndrome (TS).  Evidence indicates 
that OCD and TS may be transmitted together as an autosomal dominant trait with mixed 
expressivity, influenced in part by gender – for example, a woman carrying the diathesis 
will likely express it as OCD and not TS (24).  Clearly, future research focusing on the 
role of pregnancy and childbirth in triggering the onset of OCD would benefit from the 
inclusion of relevant genetic factors. 
   
1.f. Social Factors Which May Contribute to OCD During Pregnancy 
 
Several studies have reported an earlier onset of obsessive-compulsive disorder 
more commonly in men (age 5-15 yrs.), with a later onset (age 23-35 yrs.) more common 
in women (68, 69).  This may be evidence of gender-divergent etiological factors in 
OCD, including certain “triggering” life events for women during this time period, 
namely the birth of a child.  To further support the concept that the incidence of OCD in 
women is highest during childbearing years, it has been reported that the age of onset of 
OCD in women has a bimodal distribution, with peak incidences occurring at 13-16 and 
22-32 years of age (11).  In an investigation of the occurrence of stressful or potentially 
triggering events in the recent history of patients with OCD, Maina et al. (1999) 




report exposure to peripartum events.  This was the only significant difference found 
between OCD and control subjects in terms of number and type of life events.  In 
addition, it was observed that postpartum OCD was much more frequent in primiparae 
(75%), that it frequently follows a pre- and post-term pregnancy (62.5%) and that it is 
often associated with delivery by caesarean section (62.5%) (14).  Although there was no 
control group for comparison, these observations suggest that certain situations 
associated with increased stress to the mother (i.e., first child, obstetric complications) 
may increase the risk for development of postpartum OCD.   
In new mothers with pre-existing OCD or who are otherwise vulnerable (i.e., 
genetic or characterlogic predisposition), the responsibility of looking after a helpless, 
totally dependent infant combined with other environmental and family changes after the 
birth may be a source of significant psychological stress causing exacerbation or new 
onset of the disorder (13).  Situations such as being a single mother, an unplanned 
pregnancy, and having a poor relationship with one’s own mother may be additional risk 
factors (70).  In his study, Lo reported that 30% of his postpartum OCD patients 
exhibited a fluctuating disease course with exacerbations corresponding to environmental 
stress (9).   
       Interestingly, it appears that pregnancy and the postpartum are also vulnerable 
periods for the development of OCD in expecting fathers.  Abramowitz et al. described 
four males who presented with rapid-onset OCD symptoms associated with their spouse’s 
pregnancy or the birth of their child.  All the fathers reported unwanted obsessional 
thoughts of harming their newborn or unborn child, similar in character to those reported 




highlights the need to look beyond purely biological models to explain puerperial OCD, 
and perhaps OCD in general. 
 
1.g. Psychology – primary parental preoccupations and other adaptive behaviors 
 
From an evolutionary perspective on psychopathology, it has been proposed that 
highly conserved maternal behavior, while adaptive and crucial for reproductive success, 
also leaves women vulnerable to certain forms of mental illness, notably OCD (71).  
Maternal behavior includes creating a safe environment for the infant, cleaning, checking, 
and nursing, all of which normally become intense parental preoccupations during 
pregnancy and the postpartum period.  For both parents, the perinatal period often 
involves an altered mental state characterized by excitement and heightened sensitivity to 
environmental and emotive cues; it has been described as “almost an illness” that a parent 
must experience and recover from in order to create and sustain an environment that can 
meet the needs of the newborn (72, 73).  The infant becomes an increasingly exclusive 
focus of thought and action.  The intrusive worries that develop concerning parental 
adequacy and the infant’s safety, as well as the resultant harm avoidant behavior or 
compulsions, resemble thoughts and behaviors encountered in OCD.  Thus, it logically 
follows that some forms of OCD (i.e., perinatal) may be the result of an inappropriate 
activation or lack of down-regulation of the neural circuits normally active during the 
initial phases of parental behavior (74).   
While it is difficult to imagine the presence of aggressive thoughts toward the 




checking compulsions, especially in women with postpartum onset major depression 
(75); checking may be viewed as maternal vigilance about the infant, and thus potentially 
adaptive maternal behavior.  In her study of obsessions and compulsions in women with 
major depression (postpartum onset vs. non-postpartum onset), Wisner (1999) found that 
women with postpartum onset depression experienced a higher frequency of these 
aggressive obsessional thoughts (mostly involving harming the infant) than women with 
non-postpartum onset (75).  Moreover, Jennings et al. found the prevalence of “passing” 
aggressive thoughts among postpartum women without depression to be 6.5%, suggesting 
that unwanted thoughts concerning harm to the newborn occur fairly frequently even 
among healthy women (1 in every 15 childbearing females) (76).  
A cognitive-behavioral model has also been proposed as an explanation for 
pregnancy or postpartum onset OCD.  According to this theory, certain individuals have a 
tendency to think and behave in a certain pathological way as a result of prior 
experiences.  In the case of OCD, vulnerable individuals misappraise common and 
benign intrusive, ego-dystonic thoughts as threatening, leading to increased 
preoccupation with the thoughts and attempts to neutralize them via compulsive rituals or 
avoidance behaviors (77, 78).  Essentially, the thought is interpreted as equivalent to the 
action (i.e., thinking about violent behavior is the same as committing a violent act).  In 
this explanation, pregnancy and the postpartum period would be considered especially 
vulnerable times for the development of obsessional problems in anyone sharing 
responsibility for the infant; the more responsible one feels in a given situation, the worse 
it will seem to have violent or negative thoughts (62).  In support of this model, it would 




cognitive behavioral therapy as a treatment strategy.  However, it cannot be assumed that 
these irrational beliefs are the cause of OCD, as empirical studies have primarily been 
correlational.  In addition, it is difficult to completely ignore the neurobiological 
evidence, including the success of SSRIs as a treatment strategy.   
One possibility that has been proposed to explain the observed exacerbation of 
OCD during pregnancy and the postpartum period involves an overwhelming of one’s 
psychological coping mechanisms during these times.  Stern and Cobb (1978) reported 
that the most common underlying theme in OCD is fear of harming oneself or others 
(79).  While it may be possible for someone with these obsessions to cope with them by 
physically avoiding other people or harmful objects/situations, the physical unity a 
pregnant woman has with the fetus may overwhelm her avoidance strategies and lead to 
an acute decompensation (16). 
         
1.h. Relationship of OCD with postpartum depression and other co-morbidities 
 
In the nongravid population, major depressive disorder is the most common 
comorbid diagnosis in patients with OCD, with lifetime prevalence rates varying from 
35-80% (80-82).  A similar relationship seems to exist between postpartum OCD and 
depression.  It is unknown, however, whether OCD symptoms represent a cause or effect 
of postpartum depression.  It is also possible that OCD and depression could 
simultaneously occur as a result of an independent variable, such as neurobiological 
changes or increased social/psychological stress in the postpartum period.  Whatever the 




harming the infant is common among women with postpartum depression – up to 41% of 
mothers with depression may have thoughts of harming their infants (76).  In addition, 
the group of women with pre-existing OCD studied by Williams and Koran experienced 
postpartum depression at a rate of 37%, in comparison with the estimated annual 
prevalence of postpartum depression of 10%-13% in the general population (13).   In 
another study, 9 out of 15 women who presented with new onset OCD in the postpartum 
period developed a secondary major depression about 2-3 weeks after onset of the 
primary obsessive illness (19).  
Although these prior studies called the recurrent, ego-dystonic thoughts of 
infanticide an obsession consistent with postpartum OCD, the accuracy of this 
classification is unclear given the number of women who developed depression, in 
addition to the lack of compulsions or other obsessions more typical of OCD.  Isolated 
obsessions of infanticide occurring in late pregnancy and the postpartum period have also 
been reported in the literature as a central psychopathologic feature of women diagnosed 
with schizophrenia and depression as well as OCD (83).  Future studies are needed to 
determine whether intrusive thoughts of infanticide alone represent true OCD, depressive 
ruminations, or some other disorder all together. 
OCD patients may also have a high lifetime prevalence of panic disorder as well 
as other anxiety disorders (84).  In Sichel’s case series described above, seven of the 
patients had a history of panic disorder, suggesting a similar relationship between 
pregnancy-related OCD and other anxiety disorders, and a potential heightened 






II. Hypothesis and Study Aims 
 
The primary goal of this study was to examine the impact of pregnancy, childbirth 
and menstruation on the onset and/or exacerbation of OCD according to DSM-IIIR 
criteria in women attending a university-based OCD Clinic between 1990 and 1995.  In 
addition, we sought to examine the relationship between reports of menstrual cycle 
exacerbation in OCD symptoms and onset or exacerbation of OCD during pregnancy and 
the puerperium.  We hypothesized that: 
1.  Within female OCD, there is a subset of patients whose symptoms are  
caused or exacerbated by fluctuations in female sex hormones that take  
place in the menstrual cycle and in the course of pregnancy and  
delivery.  Thus women with OCD who reported perinatal onset or exacerbation of their 
symptoms would be more likely to experience premenstrual exacerbation of their OCD 
symptoms than those women with OCD who have experienced at least one previous 
pregnancy but deny perinatal onset or exacerbation of their disorder.  
  2.  Compared with women with a history of pregnancy but no OCD 
exacerbations, the hormonally sensitive subgroup will: 
 (a) Report specific OCD symptoms that correspond with oxytocin-related rodent 
postpartum behavior, or that are related to typical human postpartum behavior, including 
contamination concerns, checking and cleaning, and aggressive obsessions (related to 
harming the infant), which have been frequently reported in the literature.   
(b) Report a more acute onset of symptoms, (versus a gradual onset, which is 




(c) Report high rates of co-morbid affective disorders, as well as a strong family 
history of OCD and/or postpartum affective disorder.  This is based on the existing 
literature regarding the significant influence of gonadal hormones on affective disorders, 







IIIa. Subjects and Recruitment 
 
    The data for this study were drawn from the medical records and verbal reports 
of individuals referred to the Yale OCD Clinic on the Clinical Neuroscience Research 
Unit at Connecticut Mental Health Center in New Haven, CT between 1990 and 1995.  
While men enrolled in the Clinic were also interviewed, this project focused on data 
obtained from women between age 18 and 69 years who met DSM-IIIR criteria for OCD 
according to a Structured Clinical Interview for Diagnosis (85) and had no lifetime 
history of an Axis I psychotic disorder or substance dependence disorder within the 
previous year.  All participants were fluent in English.  According to consenting 
procedures of the day, women who were already discharged from the OCD Clinic were 
sent a letter notifying them that a staff member would be contacting them to conduct an 
interview of approximately 30 minutes duration.  Women were informed that the purpose 
of the interview was to obtain information about the onset and type of OCD symptoms 
they experience and how various treatments, substance use, and/or life events may have 
impacted their symptoms.  Those who wished not to participate could indicate so by 
return mail or by phone.  If such a request was not received, individuals were contacted 
by phone to conduct the interview.  Individuals who were actively enrolled in the OCD 
Clinic were interviewed when they presented for a scheduled appointment.  None of the 




For the purposes of this study, women were placed into one of two groups; Ever 
Pregnant (Preg) and Never Pregnant (NPreg) by virtue of self-report of their obstetrical 
history.  Those women who were in the Preg group were further subdivided according to 
the following parameters:  those who reported onset of OCD during pregnancy or the 
puerperium were assigned to the Puerperal Related (PR) group while those that denied 
onset of OCD related to pregnancy were assigned to the Non-Puerperal (NP) group.  
 
IIIb. Database and Assessments 
 
 During the course of their treatment in the Yale OCD Clinic, patients were 
administered a number of clinical interviews including OCD severity ratings and 
depression inventories via the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) and 
the Yale Depression Inventory (YDI), respectively (86).  This information was obtained 
from each participants Clinic record.  The primary goal of the interview, from which data 
for this study was extracted, was to develop a complete database of all the patients (both 
male and female) who had been or were enrolled in the OCD Clinic.  The database 
includes information regarding the following areas: 
a. Demographic data:  age, sex, marital status (single, married, 
divorced, widowed), race, level of education, and occupation. 
b. Clinical features of OCD:  age at onset of minor and major 
obsessive-compulsive symptoms and age of onset of the major syndrome.  
Patients were asked to characterize their obsessions and compulsions from a list 




the disease over their lifetime (episodic vs. chronic).  In order to investigate the 
relationship of their OCD symptoms to reproductive events (in women only), 
questions were asked regarding changes in symptoms prior to menses, during 
pregnancy, and in the postpartum period. 
c. Other variables:  history of substance use, medical history, prior 
psychiatric history (including co-morbid psychiatric illness), family history, and 
physical or psychological trauma. 
 
IIIc. Statistical analysis   
 
All data were summarized using descriptive statistics (means, SDs, 
frequencies).  Continuous measures were compared between groups using a Student's t-
test and categorical variables were assessed using the chi-square test.  All analyses were 





IVa. Subjects - Pregnant versus Never Pregnant Group Comparisons 
  Of 140 potential subjects, sufficient data on OCD symptoms in relation to 
pregnancy was obtained in 126 women.  Since this was the primary focus of our study, 
data from the remaining 14 subjects were not included in any analyses.  Seventy-eight 
women reported having had at least one pregnancy (Preg Group), while 48 women 




Descriptive information for the Preg and NPreg groups is presented in Table 1. 
Mean age ± SD at presentation to the Yale OCD Clinic was significantly younger in the 
NPreg Group (32.6 ± 13 years) than the Preg Group (40.8 ± 10.8 years) (t=3.82, df=123, 
p<0.0002).  However, there was no significant difference in age at onset of OCD in the 
Preg Group (26 ± 9 years) compared to the NPreg Group (23.8 ± 10.6 years) (t=1.22, 
df=120, p=0.70).  The Preg group is comprised of 92.0% Caucasian women, 6.7% 
Hispanic women, and 1.3% other, while the NPreg group is comprised of 98% Caucasian 
and 2% Hispanic women.  Compared to women in the NPreg Group, women in the Preg 
Group were more likely to be married (X2= 40.5, df =2, p<0.0001) and less educated 
(X2=6.4, df=2, p=0.04).  Finally, there were no significant differences regarding 
comorbid diagnoses or family psychiatric history (including only professionally 
diagnosed illness).  The majority of women in both groups reported a personal and family 
history of depression, substance abuse, and/or other anxiety disorder.  Of the women who 
reported having co-morbid psychiatric diagnoses, the majority (in all groups) said that 
OCD presented first.  A minority of subjects reported onset of depression or 
trichotillomania before OCD, and one subject who reported OCD onset related to 
pregnancy presented with new onset OCD and postpartum depression simultaneously.   
 
Pregnancy Related Onset versus Onset Unrelated to Pregnancy Subgroup 
Comparisons 
Of the Preg group, 24 (30.8%) fell into the PR subgroup by virtue of having 
reported the onset of OCD to be related to either pregnancy, fetal loss, or the postpartum 




onset after a miscarriage, and 12 (15.4%) had onset during the postpartum period.  Thus, 
roughly half of the PR subgroup experienced onset during pregnancy while the other half 
experienced onset during the puerperium.  Table 2 provides descriptive information for 
the PR and NP subgroups.  Mean age ± SD on admission for the PR (39.3 ± 8.2 years) 
and NP (41.5 ±11.8) groups was similar, as was age at onset of OCD (PR subgroup 27 ± 
7.1; NP subgroup 25.6 ± 9.8).  There were no significant differences in any between 
subgroup comparisons with the exception that more women in the NP (22.2%) than in the 
PR subgroup (4.2%) carried a comorbid diagnosis which fell into our category of “other” 
(X2=3.9, df=1, p=0.05).  This category included diagnoses such as trichotillomania, 
eating disorders, and Tourette’s syndrome.  In addition, women in the NP subgroup 
(22.2%) were more likely to report a family history of substance abuse than women in the 
PR subgroup (4.2%) (X2=3.9, df=1, p=0.05).  While Yale Brown Obsessive Compulsive 
Scale (YBOCS) Scores obtained on admission to the OCD Clinic were available on 
roughly half of the women in each subgroup, there was a trend for women in the PR (29.5 
± 7.0) to have higher YBOCS Scores than women in the NP subgroup (25.7 ± 4.9) 
(t=1.93, df=35, p=0.06).  YBOCS Scores in this range are consistent with moderate to 
severe illness.  This is reflected in the baseline global assessment of function (GAF) 
scores which were lower in the PR subgroup (51.6 ± 7.1) but not significantly different 
from that in the NP (56.3 ± 14.0). 
 
IVb. Course and Characteristics of OCD: 




As mentioned, there was no significant difference found between the Preg and 
NPreg groups in the age of onset of OCD, and the vast majority (greater than 95%) 
described their course of illness as chronic rather than episodic.  A greater proportion of 
women who had been pregnant reported acute onset of symptoms (47.8%), but this did 
not differ statistically from women who had never been pregnant (31.4%) (X2=2.56, 
df=1, p=0.11). 
The frequency of specific types of OCD symptoms in the Preg and NPreg groups 
is depicted in Table 6.  Significant differences in specific types of symptoms were present 
only for religious/scrupulosity obsessions (X2=6.01, df=1, p=0.01), ordering/arranging 
compulsions (X2=5.51, df=1, p=0.02), and miscellaneous compulsions (X2=6.633, df=1, 
p=0.01).  There was also a trend for women in the NPreg Group to report having sexual 
obsessions (X2=3.25, df=1, p=0.07) and a greater number of symptoms overall (t=1.8, 
df=123, p=0.07).  Approximately 21% of women with OCD who had been pregnant 
experienced obsessions regarding harming their infant. 
 
   PR and NP Subgroup Comparisons 
Women with pregnancy-related onset of OCD had a similar number of 
pregnancies as those with OCD onset unrelated to pregnancy, although onset of OCD 
with pregnancy was most likely to occur during or after the first pregnancy (Table 4).  As 
was expected with any index event serving as a trigger for symptom onset, 62% of 
women in the PR subgroup reported acute onset of OCD symptoms compared to 42% in 
the NP subgroup.  However, this difference was not statistically significant (X2=2.4, 




the question of how long after delivery their symptoms began.  Seven out of the 10 
reported that the onset of their OCD occurred “right away,” while the remainder reported 
onset of symptoms within the first 6 months after delivery.   
Type of obsessions and compulsions reported as primary symptoms by the PR and 
NP subgroups is described in Table 7.  Only obsessions regarding contamination were 
significantly greater in the PR subgroup (66.7%) versus the NP subgroup (35.9%) 
(X2=6.33, df=1, p=0.01).  Interestingly, aggressive obsessions regarding the infant did not 
differ statistically.   
  
IVc. Changes in Existing OCD During Pregnancy and the Premenstruum: Group and 
Subgroup Comparisons 
Women in the Preg group who had onset of OCD prior to becoming pregnant 
reported worsening of symptoms with pregnancy in 45 (34.1%) cases, no change in 58 
(43.9%), and improvement in 29 (22.0%).  These results are reported in terms of 
pregnancies (rather than percentage of women) since nine women reported an 
exacerbation of OCD symptoms during one pregnancy, yet an improvement or no change 
during another.  Women in the Preg and NPreg groups experienced worsening of 
symptoms prior to menses at approximately the same rate (48.4% of Preg, 51.6% of 
NPreg – see Table 3).  As shown in Table 5, when women in the PR group were 
combined with those who reported any pregnancy-related worsening, there was a 
significant association with premenstrual worsening of OCD symptoms (X2=3.93, df=1, 









Pregnancy and childbirth are characterized by enormous physiologic and 
psychological demands for the woman.  The findings from our study add to the growing 
literature suggesting that pregnancy and childbirth can trigger the onset of OCD or the 
exacerbation of the ongoing disorder in a substantial number of women.  Our discovery 
that roughly 30% of women experienced a perinatal related onset of the disorder is 
similar to that reported by others (10, 11).  The predicted relationship between 
pregnancy-related symptoms and PMS related symptoms was confirmed, suggesting that 
there is a "hormone related" subtype of OCD in women.  Women with pregnancy-related 
onset of OCD or perinatal worsening of pre-existing OCD are more likely to experience 
premenstrual exacerbation of their OCD symptoms when compared to those women with 
previous pregnancies but onset of OCD outside the perinatal period or no perinatal 
worsening.  This latter finding is similar to what has been observed in  affective disorders 
such as PMDD and PPD (87).  In terms of changes in preexisting OCD, our results about 
changes during pregnancy are in agreement with previous studies, which reported both 
improvement and worsening of symptoms at this reproductive event. 
In terms of specific symptoms present among our subjects, although there was a 
significantly greater amount of contamination obsessions reported by the PR group 
(which is consistent with prior research), we were surprised to find no significant 
difference between the groups in obsessions or compulsions related to typical postpartum 




with postpartum OCD would be more likely to have these types of symptoms as 
abnormal manifestations of normal maternal behavior.  In addition, there was no 
significant difference found between the PR and NP groups in terms of having aggressive 
obsessions (including related to harming the infant), and there was a lower than expected 
proportion of women in the PR group (25%) reporting worries about aggression or harm 
to the infant.  These findings are likely due to the stigma surrounding having these 
thoughts, and the resulting fear of admitting their presence in an interview format. 
Although, as described above, a majority of women in the PR subgroup reported 
acute onset of OCD symptoms, our hypothesis that this would differ significantly from 
that reported by women with onset unrelated to pregnancy was not supported. 
The comorbidity rate of about 65% of mood disorders (primarily major 
depression) in both groups of women is consistent with the results of previous research.   
However, our hypothesis that this percentage would be higher in the PR group versus the 
NP group was not supported.  Moreover, in this sample and with the measures available, 
we did not find a significant difference between the groups in terms of family history of 
OCD or postpartum OCD/affective disorders. 
 
Study Limitations: 
Based on the retrospective studies that have been done, as many as 11% to 47% of 
women have their first onset of OCD in the peripartum period (13, 14, 92).  Our results 
also suggest that both pregnancy and the postpartum may be periods of risk for the 
initiation of OCD, with the two periods conferring relatively equal risk.  However, the 




recall.  As discussed, there are no prospective studies analyzing the course of OCD 
during different reproductive events.  Future prospective studies are necessary to further 
clarify the prevalence of OCD during pregnancy and the postpartum period, as well as to 
identify subgroups of women who may be particularly vulnerable to the development of 
this disorder.  Another limitation of our study is the relatively small sample size, which 
reduces statistical power and makes it difficult to obtain definitive conclusions.  If the 
sample size was increased, some of our negative results may have achieved significance.  
In addition, this study did not investigate changes in symptom severity specifically in the 
postpartum period; this is a definite weakness, as some women may have not been able to 
distinguish between pregnancy and the postpartum period when asked to recall changes 
in their symptoms at that time.  Again, prospective assessments could address this 
weakness in the present research.   
 
Future Directions: 
In reviewing the literature, several suggestions can be made for future studies.  
Based on the results of Maina’s study, which showed that postpartum OCD was much 
more frequent in the context of certain pregnancy complications or characteristics (14), 
future studies should include an assessment of obstetric complications in women with 
peripartum OCD symptoms.  In addition, more studies need to consider the role of 
breastfeeding, as this extends and contributes to the period of hormonal fluctuations and 
often delays the return of the ovarian cycle.  Regarding obsessions of harming the infant, 




level of distress induced, and the mother’s assessment of the likelihood that she would 
carry out such thoughts. 
Likewise, in future studies, greater emphasis should be placed on determining 
comorbid psychiatric diagnoses, as there is a high rate of comorbidity between OCD and 
major depression, even when related to pregnancy.  In terms of treatment, the efficacy of 
high-potency dopaminergic antagonists in the treatment of certain OCD patients, as well 
as evidence linking dopamine excess to compulsive behaviors, argue for further 
exploration of the dopaminergic system.  
 
Conclusions: 
Even if no physical harm is done to the infant as a result of a mother’s obsessional 
thoughts, these thoughts may negatively affect the infant’s development in a variety of 
ways.  For example, mothers who fear harming their infants may avoid them as a result, 
preventing the development of a secure mother-child relationship and affecting proper 
infant care.  In addition, these obsessional thoughts likely affect a mother’s confidence in 
her abilities, and may further hinder the development of a close relationship with her 
child (76).  Increasing data shows that a poor early interaction between the parent and the 
infant may have detrimental long-term effects on the child, including increased 
vulnerability to stress and an increased risk for developing psychiatric disorders later in 
life (88, 89).  Animal studies have also highlighted the importance of early mothering in 
determining the future maternal behavior of the adult offspring (90, 91). 
OCD in the peripartum period is probably an underdiagnosed entity.  It is thus 




potential consequences, so that early intervention may take place.  Women should be 
reassured that the occurrence of intrusive ego-dystonic thoughts is common, so that they 
may receive appropriate care without having to suffer in silence.  Also, the extent to 
which peripartum OCD predicts increased likelihood of recurrence of the disorder during 
or after future pregnancies needs to be investigated, and if possible, prophylactic efforts 
should be made.  Given current theories on the etiology of puerperal mental illness, it 
may be helpful for physicians to inquire about the severity of PMS symptoms, as well as 
personal and family psychiatric history, when attempting to perform risk assessment for a 
patient.  
That approximately half (46-56%) of all of the women in this study, regardless of 
pregnancy history, reported a worsening of OCD symptoms during the premenstruum 
suggests that clinicians should consider the premenstruum as a trigger for symptom 
exacerbation and make decisions regarding treatment accordingly.  Women with OCD 
who feel that their symptoms worsen in the premenstruum should keep a daily diary of 
symptom severity similar to that which is done by women undergoing evaluation for 
premenstrual dysphoric disorder.  As a goal for future research, it would be interesting to 
prospectively assess the premenstruum and the puerperium in the same group of patients 
to determine if worsening of OCD during the premenstruum could act as a predictor of 
worsening or onset related to pregnancy. 
Despite the limitations acknowledged above, our findings provide additional 
evidence that pregnancy and childbirth are frequently associated with the onset of OCD 
or worsening of symptoms in those with pre-existing disorder.  In addition, the results of 




phenomenon; there appears to be continuity between OCD onset and/or exacerbation 
across the reproductive life cycle, at least with menstruation and pregnancy.  Although 
the premenstruum, pregnancy, and postpartum periods all have differing hormonal shifts, 
they can all be characterized as hormonally unstable periods relative to other times in a 
woman’s life cycle.  Appreciating and understanding the role these hormones play in 
influencing the course of OCD may help to elucidate potential neurobiological 
mechanisms of this psychopathology, and will hopefully lead to the development of new 
concepts in treatment.  However, concurrent with these hormonal fluctuations are 
dramatic and potentially stressful changes in the mother’s psychosocial and interpersonal 
situation.   Future studies will need to be designed in such a manner to begin to tease 
apart the relative contributions incorporated in the biopsychosocial model of the 






Table 1.  Demographic and Clinical Information - Preg vs. 
NPreg 
            
   
Pregnant 








(%)   
Age on Admission 77 40.8±10.8 48 32.6±13.0 
t=3.82, df=123, 
P=.0002
        
Race        
    Caucasian 69 (92) 47 (98) X2=2.01, df=2, P=.37
    Hispanic 5 (6.7) 1 (2)  
    Other 1 (1.3) 0 (0)  
        
Marital        
    Single 8 (10.4) 31 (64.6) 
X2=40.5, df=2, 
P=.0001
    Married 54 (70.1) 14 (29.2)  
    Divorced 15 (19.5) 3 (6.3)  
        
Education        
    H.S. or less 31 (40.8) 10 (21.3) X2=6.4, df=2, P=.04
    Technical 
school/partial 
college 15 (19.7) 17 (36.2)  
    College or 
professional school 30 (39.5) 20 (42.3)  
        
Baseline Y-BOCS 37 27.0±5.9 26 25.1±5.9 t=1.27, df=61, P=.21
Baseline GAF 58 54.8±12.3 40 55.4±10.9 t=0.24, df=96, P=.81
Age onset of OCD 76 26.0±9.0 46 23.8±10.6 t=1.22, df=120, P=.23
Number prior 
psych 
hospitalizations 78 1.0±1.7 47 0.9±1.5 t=0.39, df=123, P=.70
        
Co-morbid 
diagnoses        
    Any 48 (61.5) 34 (70.8) X2=1.13, df=1, P=.29
    Substance abuse 0 (0) 1 (2.1) X2=1.64, df=1, P=.20





    Other anxiety 
disorder 10 (12.8) 7 (14.6) X2=0.08, df=1, P=.78
    Other 13 (16.7) 11 (22.9) X2=0.75, df=1, P=.39
        
Family history        
    Any 69 (90.8) 39 (81.3) X2=2.38, df=1, P=.12
    Substance abuse 13 (16.7) 9 (18.8) X2=0.09, df=1, P=.76
    Affective disorder 18 (23.1) 12 (25.0) X2=0.06, df=1, P=.81
    OCD 9 (11.5) 3 (6.3) X2=0.96, df=1, P=.33
    Other anxiety 
disorder 3 (3.9) 0 (0) X2=1.89, df=1, P=.17



















Table 2. Demographic and Clinical Information - PR vs. NP 
            
   
Pregnancy 
Related 









(%)   
Age on Admission 24 39.3±8.2 53 41.5±11.8 
t=0.81, df=75, 
P=.42 
        
Race        
    Caucasian 21 (91.3) 48 (92.3) 
Χ2=2.53, df=2, 
P=.28
    Hispanic 1 (4.4) 4 (7.7) 
    Other 1 (4.3) 0 (0) 
        
Marital        
    Single 4 (16.7) 4 (7.6) 
Χ2=1.52, df=2, 
P=.47
    Married 16 (66.7) 38 (71.7) 
    Divorced 4 (16.7) 11 (20.7) 
        
Education        
    H.S. or less 8 (33.3) 23 (44.2) 
Χ2=1.01, df=2, 
P=.60
    Technical 
school/partial college 6 (25.0) 9 (17.3) 
    College or 
professional school 10 (41.7) 20 (38.5) 
        
Baseline Y-BOCS 13 29.5±7.0 24 25.74.9 
t=1.93, df=35, 
P=.06
Baseline GAF 19 51.6±7.1 39 56.314.0 
t=1.36, df=56, 
P=.18
Age onset of OCD 24 27.0±7.1 52 25.59.8 
t=0.70, df=74, 
P=.49
Number prior psych 
hospitalizations 24 1.2±2.0 54 0.91.6 
t=0.67, df=76, 
P=.51
        
Co-morbid diagnoses        
    Any 13 (54.2) 35 (64.8) 
X2=0.80, df=1, 
P=.37
    Substance abuse 0 (0) 0 (0) N/A





    Other anxiety disorder 4 (16.7) 6 (11.1) 
X2=0.46, df=1, 
P=.50
    Other 1 (4.2) 12 (22.2) 
X2=3.9, df=1, 
P=.05
        
Family history        
    Any 20 (87.0) 49 (92.5) 
X2=0.58, df=1, 
P=.45
    Substance abuse 1 (4.2) 12 (22.2) 
X2=3.90, df=1, 
P=.05
    Affective disorder 5 (20.8) 13 (24.1) 
X2=0.10, df=1, 
P=.75
    OCD 2 (8.3) 7 (13.0) 
X2=0.35, df=1, 
P=.55
    Other anxiety disorder 1 (4.2) 2 (3.7) 
X2=0.10, df=1, 
P=.92








Table 3. OCD and Reproductive Events - Preg vs. NPreg 
            
   
Pregnant 








(%)   
Number of 
pregnancies 68 2.5±1.5   N/A N/A
        
Number of 
abortions/miscarriage
s 66 0.5±0.8  N/A N/A
        
Lifetime course of 
OCD        
    Episodic 3 (4.2) 0 (0) 
X2=1.84, df=1, 
P=.18
    Chronic 69 (95.8) 43 (100)  
        
Initial onset of major 
syndrome        
    Acute 33 (47.8) 11 (31.4) 
X2=2.56, df=1, 
P=.11
    Gradual 36 (52.2) 24 (68.6)  
        
Symptom changes 
prior to menses        
    No change 27 (43.5) 14 (45.2)   
    Worse 30 (48.4) 16 (51.6) 
X2=0.81, df=2, 
P=.67
    Uncertain 5 (8.1) 1 (3.2)  
        
Onset - pregnancy       
    No 66 (84.6)  N/A N/A
    Yes 12 (15.4)    
        
Onset - post loss        
    No 18 (94.7)  N/A N/A
    Yes 1 (5.3)    




Onset - postpartum        
    No 66 (84.6)  N/A N/A
    Yes 12 (15.4)       
 
 
Table 4. OCD and Reproductive Events - PR vs. 
NP  






























        
Lifetime course of 
OCD        
    Episodic 1 (4.8) 2 (3.9) 
Χ2=0.03, df=1, 
P=.87




9 (96.1)  
        
Initial onset of major 
syndrome        







    Gradual 8 (38.1) 
2
8 (58.3)  
        
Symptom changes 
prior to menses        





    Worse 9 (56.3) 
2
1 (45.7)  
    Uncertain 1 (6.2) 4 (8.7)  
        




    No 
1
2 (50.0)   N/A N/A
    Yes 
1
2 (50.0)     
        
Onset - post loss         
    No 7 (87.5)   N/A N/A
    Yes 1 (12.5)     
        
Onset - postpartum         
    No 
1
2 (50.0)   N/A N/A
    Yes 
1
2 (50.0)      
 
 
Table 5. OCD and Reproductive Events - Combined Analysis 














menses      
    No 
change 10 (34.5) 17 (60.7)  








Table 6. Major OCD Symptoms - Preg vs. NPreg 







  N (%) N (%)  
Major OCD Symptoms      
    Aggressive 22 (28.6) 18 (37.5) Χ2=1.08, df=1, P=.30
    Contamination 35 (45.5) 23 (47.9) Χ2=0.07, df=1, P=.79
    Sexual 4 (5.2) 7 (14.6) Χ2=3.25, df=1, P=.07
    Hoarding/saving 5 (6.5) 6 (12.5) Χ2=1.33, df=1, P=.25
    Religious/scrupulosity 3 (3.9) 8 (16.7) Χ2=6.01, df=1, P=.01
    Symmetry/exactness 17 (22.1) 13 (27.1) Χ2=0.41, df=1, P=.52
    Somatic/illness 5 (6.5) 4 (8.3) Χ2=0.15, df=1, P=.70
    Misc. obsessions 23 (30) 15 (31) Χ2=0.03, df=1, P=.87
    Cleaning/washing 45 (58.4) 23 (47.9) Χ2=1.32, df=1, P=.25
    Checking 38 (49.4) 27 (56.3) Χ2=0.56, df=1, P=.45
    Repeating 24 (31.2) 18 (37.5) Χ2=0.53, df=1, P=.47
    Counting 12 (15.6) 11 (22.9) Χ2=1.06, df=1, P=.30
    Ordering/arranging 17 (22.1) 3 (6.3) Χ2=5.51, df=1, P=.02
    Collecting 5 (6.5) 8 (16.7) Χ2=3.28, df=1, P=.07
    Misc. compulsions 11 (14.3) 16 (33.3) Χ2=6.33, df=1, P=.01
    Worry - aggression/harm to 
babies 16 (20.8) n/a  
       





(n=48) t=1.8, df=123, P=.07










Table 7. Major OCD Symptoms - PR vs. NP  










  N (%) N (%)  
Major OCD Symptoms      
    Aggressive 5 (20.8) 17 (32.1) 
X2=1.02, df=1, 
P=.31
    Contamination 16 (66.7) 19 (35.9) 
X2=6.33, df=1, 
P=.01
    Sexual 1 (4.2) 3 (5.7) 
X2=0.07, df=1, 
P=.78
    Hoarding/saving 0 (0) 5 (9.4) 
X2=2.42, df=1, 
P=.12
    Religious/scrupulosity 1 (4.2) 2 (3.8) 
X2=0.01, df=1, 
P=.93
    Symmetry/exactness 6 (25.0) 11 (20.8) 
X2=0.17, df=1, 
P=.68
    Somatic/illness 2 (8.3) 3 (5.7) 
X2=0.19, df=1, 
P=.66
    Misc. obsessions 6 (25.0) 17 (32.1) 
X2=0.39, df=1, 
P=.53
    Cleaning/washing 17 (10.8) 28 (52.8) 
X2=2.20, df=1, 
P=.14
    Checking 12 (50.0) 26 (49.1) 
X2=0.01, df=1, 
P=.94
    Repeating 8 (33.3) 16 (30.2) 
X2=0.08, df=1, 
P=.78
    Counting 1 (4.2) 11 (20.8) 
X2=3.46, df=1, 
P=.06
    Ordering/arranging 6 (25.0) 11 (20.8) 
X2=0.17, df=1, 
P=.68
    Collecting 0 (0) 5 (9.4) 
X2=2.42, df=1, 
P=.12
    Misc. compulsions 2 (8.3) 9 (17.0) 
X2=1.01, df=1, 
P=.32
    Worry - aggression/harm to 
babies 6 (25.0) 10 (18.9) 
X2=0.38, df=1, 
P=.54
       
Total number of major 
symptoms 3.7±1.3 (n=24) 3.6±1.5 (n=53) 
t=0.19, df=75, 
P=.85
Note: One woman in the Onset Unrelated to Pregnancy Group did not have this 
information thus sample size for this table is N=53 
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